D4J-19540-68974
3 vaccinations
8 coded responses
23 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 502 / IA
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Registered in v-safe
-
2021-03-17
Dose 1 — Pfizer-BioNTech
-
2021-03-17
Survey response — day 0, dose 1MedDRA: Immediate post-injection reaction, Injection site pain, Injection site paraesthesia — Feeling: GoodFree text: Minimal tingling/pain at injection sight the first 20 minutes of receiving it. None since.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Survey response — days 1–6 daily, dose 1MedDRA: Myalgia — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Muscle and body aches are localized to neckMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-04-02
- 2021-04-07
-
2021-04-08
Dose 2 — Pfizer-BioNTech
- 2021-04-09
- 2021-04-10
-
2021-04-11
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: Good · Site: PainFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-14
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
-
2021-05-20
Survey response — day 42, dose 2MedDRA: Nodule — Feeling: GoodFree text: Spherical nodule under skin/tissue in arm that shot was given in.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-09
-
2021-10-19
Dose 3 — Pfizer-BioNTech
-
2022-04-24
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis, Secretion discharge — Feeling: FairFree text: Cold, drainage, mucusMedDRA releases: 2024-11 · check-in free text available
-
2022-10-19
Survey response — 12 months, dose 3MedDRA: COVID-19, Cough, Fatigue, Headache, Oropharyngeal pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid positive, started with a bit of a sore throat and cough, had a fever the day after (lasted one day), sore throat continued for 3 days, tired, headache as well. Symptoms started to improve after thisMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech | |
| 3 | 2021-10-19 | Pfizer-BioNTech | No |
Free text
Release 5 — day 0, dose 1
Systemic reaction (other): Minimal tingling/pain at injection sight the first 20 minutes of receiving it. None since.
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Muscle and body aches are localized to neck
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Bruising at injection site
Systemic reaction (other): Bruising at injection site
Systemic reaction (other): Bruising at injection site
Release 8 — day 42, dose 2
Symptoms: Spherical nodule under skin/tissue in arm that shot was given in.
Release 11 — 6 months, dose 3
Symptoms: Cold, drainage, mucus
Release 12 — 12 months, dose 3
Symptoms: Covid positive, started with a bit of a sore throat and cough, had a fever the day after (lasted one day), sore throat continued for 3 days, tired, headache as well. Symptoms started to improve after this
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nodule | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site paraesthesia | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release